Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cartela R & D AB
AB
Active
Org 5567460083
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2007
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cartela R & D AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SB
Stefan Bo Lundberg
Audit
Audit
2020
Former (2)
DA
Dan Allan Kjellqvist
Audit
Audit
2020 – 2022
JE
Jonas Ebbe Nihlberg
Authorized Recipient of Service
Authorized Recipient of Service
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
AK
Anne Katarina Säfström Lanner
Deputy Board Member
2024
MM
Monika Maria Törnsén
Chairman
2025
CS
Christina Sofie Sjöström
Board of Directors
2024
Former (5)
FG
Ferdinand Gregor Winter
Chairman
2024 – 2025
LK
Lúdvík Karl Tómasson
Board of Directors
2022 – 2023
DS
Donato Spota
Chairman
2022 – 2024
EV
Eva-Maria Viktoria Joed
Deputy Board Member
2020 – 2022
FE
Fredrik Emanuel Björne
Board of Directors
2020 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Hansa Biopharma AB
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Cartela R & D AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network